Pfizer's maternal RSV vaccine

The U.S. Food and Drug Administration (FDA) has granted approval to Pfizer’s maternal RSV vaccine for RSV-related lower respiratory tract disease (LRTD) and severe LRTD in infants

by

Pfizer’s Maternal RSV Vaccine The U.S. Food and Drug Administration (FDA) approved Pfizer’s maternal RSV vaccine for the purpose of combating RSV-related lower respiratory tract disease (LRTD) and severe LRTD in infants which is known as brand name Abrysv. It is intended for administration between 32 and 36 weeks of gestation and is delivered through a single-dose injection into the muscle. With it, the United States became the first country to approve a vaccine for pregnant women that prevents severe disease caused by Respiratory Syncytial Virus (RSV) in their babies. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research on Monday “RSV is a common cause of illness in children, and infants are among those at highest risk for severe disease, which can lead to hospitalization,”

Pfizer’s maternal RSV vaccine

A. ) RSV (Respiratory Syncytial Virus)

It is the primary cause of lower respiratory tract disease (LRTD) in infants resulting into lower respiratory tract disease (LRTD) like bronchiolitis and pneumonia during  first three months of life, while leading to bronchiolitis, pneumonia, and other life-threatening conditions. Infants, especially those in their first year of life, face the highest risk of RSV-associated LRTD. It has a seasonal pattern, circulating during fall and peaking during the winter months. The virus was first found in the year 1956 in nasal secretions of chimpanzees with rhinorrhea and coryza and was initially named “Chimpanzee coryza agent” (CCA).

Respiratory Syncytial Virus (RSV)

Pfizer’s maternal RSV vaccine

https://www.cnn.com/2022/10/31/health/rsv-vaccines-therapies/index.html

Against whom do the U.S. Food and Drug Administration (FDA) has granted approval to Pfizer?

Against Pfizer’s maternal RSV vaccine, has the U.S. Food and Drug Administration (FDA) granted approval to Pfizer

Related Posts